Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Hyaluronic acid concentration in postmenopausal facial skin after topical estradiol and genistein treatment: a double-blind, randomized clinical trial of efficacy.

Patriarca MT, Barbosa de Moraes AR, Nader HB, Petri V, Martins JR, Gomes RC, Soares JM Jr.

Menopause. 2013 Mar;20(3):336-41. doi: 10.1097/GME.0b013e318269898c.

PMID:
23435032
2.

The effects of topical isoflavones on postmenopausal skin: double-blind and randomized clinical trial of efficacy.

Moraes AB, Haidar MA, Soares Júnior JM, Simões MJ, Baracat EC, Patriarca MT.

Eur J Obstet Gynecol Reprod Biol. 2009 Oct;146(2):188-92. doi: 10.1016/j.ejogrb.2009.04.007. Epub 2009 May 17.

PMID:
19450919
3.

Collagen concentration on the facial skin of postmenopausal women after topical treatment with estradiol and genistein: a randomized double-blind controlled trial.

Silva LA, Ferraz Carbonel AA, de Moraes ARB, Simões RS, Sasso GRDS, Goes L, Nunes W, Simões MJ, Patriarca MT.

Gynecol Endocrinol. 2017 May 16:1-4. doi: 10.1080/09513590.2017.1320708. [Epub ahead of print]

PMID:
28508697
4.

The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.

Le Donne M, Caruso C, Mancuso A, Costa G, Iemmo R, Pizzimenti G, Cavallari V.

Arch Gynecol Obstet. 2011 Jun;283(6):1319-23. doi: 10.1007/s00404-010-1545-7. Epub 2010 Jun 25.

PMID:
20577750
5.

Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo.

Rittié L, Kang S, Voorhees JJ, Fisher GJ.

Arch Dermatol. 2008 Sep;144(9):1129-40. doi: 10.1001/archderm.144.9.1129.

PMID:
18794456
6.

Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.

Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC.

Obstet Gynecol. 2007 Mar;109(3):588-96.

PMID:
17329509
7.

Effects of topical estradiol on the facial skin collagen of postmenopausal women under oral hormone therapy: a pilot study.

Patriarca MT, Goldman KZ, Dos Santos JM, Petri V, Simões RS, Soares JM Jr, Simões MJ, Baracat EC.

Eur J Obstet Gynecol Reprod Biol. 2007 Feb;130(2):202-5. Epub 2006 Jun 23.

PMID:
16797821
9.

Serum concentrations of 17beta-estradiol and estrone after multiple-dose administration of percutaneous estradiol gel in symptomatic menopausal women.

Brennan JJ, Lu Z, Whitman M, Stafiniak P, van der Hoop RG.

Ther Drug Monit. 2001 Apr;23(2):134-8.

PMID:
11294513
11.

Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.

D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Adamo EB, Squadrito F.

Menopause. 2009 Mar-Apr;16(2):301-6. doi: 10.1097/gme.0b013e318186d7e2.

PMID:
19034051
13.

Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study.

Squadrito F, Altavilla D, Crisafulli A, Saitta A, Cucinotta D, Morabito N, D'Anna R, Corrado F, Ruggeri P, Frisina N, Squadrito G.

Am J Med. 2003 Apr 15;114(6):470-6.

PMID:
12727580
14.

Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.

Pinkerton JV, Shifren JL, La Valleur J, Rosen A, Roesinger M, Siddhanti S.

Menopause. 2003 Jan-Feb;10(1):45-52.

PMID:
12544676
15.

Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.

Schaefers M, Muysers C, Alexandersen P, Christiansen C.

Menopause. 2009 May-Jun;16(3):559-65. doi: 10.1097/gme.0b013e31818ebfba.

PMID:
19423999
16.
17.

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR.

Psychoneuroendocrinology. 1999 Aug;24(6):657-77.

PMID:
10399774
18.

Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study.

Jonasson AF, Edwall L, Uvnäs-Moberg K.

Menopause Int. 2011 Dec;17(4):120-5. doi: 10.1258/mi.2011.011030. Epub 2011 Nov 25.

PMID:
22120944
19.

Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.

D'Anna R, Cannata ML, Atteritano M, Cancellieri F, Corrado F, Baviera G, Triolo O, Antico F, Gaudio A, Frisina N, Bitto A, Polito F, Minutoli L, Altavilla D, Marini H, Squadrito F.

Menopause. 2007 Jul-Aug;14(4):648-55.

PMID:
17251874
20.

Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.

Archer DF; EstroGel Study Group.

Menopause. 2003 Nov-Dec;10(6):516-21.

PMID:
14627859

Supplemental Content

Support Center